We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

BRUKER

BRUKER offers high-performance scientific instruments and high-value analytical and diagnostic solutions that enable ... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
21 Jun 2021 - 24 Jun 2021

Serum Based Antigen Test Detects Childhood Tuberculosis

By LabMedica International staff writers
Posted on 01 Jun 2021
Print article
Image: Computer-generated Mycobacterium tuberculosis bacteria, Ziehl-Neelsen stain. The reagents used are carbol fuchsin, acid alcohol, and methylene blue counterstain Acid-fast bacilli stain red and the background is blue (Photo courtesy of  microbiologyinpictures)
Image: Computer-generated Mycobacterium tuberculosis bacteria, Ziehl-Neelsen stain. The reagents used are carbol fuchsin, acid alcohol, and methylene blue counterstain Acid-fast bacilli stain red and the background is blue (Photo courtesy of microbiologyinpictures)
Approximately one million children develop tuberculosis (TB) and 205,000 die of TB-related causes each year. Eighty percent of these deaths occur in children < 5 years old, with the majority (96%) of deaths occurring among children who did not receive treatment, where missed diagnoses are likely responsible for undertreatment.

Children with TB, particularly infants, frequently have paucibacillary TB, exhibit non-specific symptoms, and are likely to rapidly progress to disseminated or extrapulmonary TB in the absence of appropriate treatment. This clinical presentation, combined with difficulty obtaining respiratory samples, makes it challenging to diagnose pediatric TB and monitor treatment responses using standard sputum-based methods.

A multidisciplinary team of medical scientists led by Tulane University School of Medicine (New Orleans, LA, USA) used a small blood sample that can be easily obtained from children of any age to detect a specific protein (CFP-10) that the bacteria secrete to maintain the infection that develops into TB. Since this protein is present at very low levels in the blood, the assay uses an antibody specific for this protein to enrich it from other proteins in blood and a mass spectrometer to detect it with high sensitivity and accuracy.

The team used this test to screen stored blood samples collected from 284 HIV-infected and 235 children without the virus who participated in a large clinical trial conducted from 2004 to 2008. Serum CFP-10pep was analyzed using a nanoparticle-based immunoenrichment assay read by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) (Bruker Microflex LRF, Bremen, Germany) that detects Mtb-specific CFP-10pep from trypsin-digested serum or EDTA plasma samples.

The group found their test identified children diagnosed with TB by the current gold-standard TB tests with 100% accuracy. The assay also detected 83.7% of TB cases that were missed by these tests, but that were later diagnosed by a standard checklist employing an array of other information collected by each child's physician (unconfirmed TB cases). The test also detected CFP-10 in 77% of the blood samples that were collected 24 weeks before children were diagnosed with TB by other methods, indicating its strong potential for early TB diagnosis. The biomarker from some positive cases can be detected as early as 60 weeks before their TB diseases were confirmed.

Tony Y. Hu, PhD, a Professor of Biochemistry and Molecular Biology and senior author of the study, said, “This is a breakthrough for infants with tuberculosis because we don't have this kind of screening technology to catch early infections among those youngest groups who are most likely to be undiagnosed. I hope this method can be pushed forward quickly to reach these children as early as possible.”

The authors concluded that their results suggest that serum CFP-10pep signal could improve TB diagnosis in children, as it exceeds the WHO-specified sensitivity requirements for new non-sputum diagnostics, and exhibits similar performance for all TB manifestations, including culture-negative TB, HIV/TB co-infection, and extrapulmonary TB, which are normally challenging to diagnose. The study was published on May 18, 2021 in the journal BMC Medicine.

Related Links:
Tulane University School of Medicine
Bruker


New
Gold Supplier
Molecular & Immunoassay Diagnostic Analyzer
Randox Discovery
New
SARS-CoV-2 RT-PCR Test
Promotor SARS-CoV-2 RT-PCR Test Kit
New
COVID-19 Detection Kits
PCR Diagnostic Solution
New
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer

Print article
BIOHIT  Healthcare OY

Channels

Clinical Chem.

view channel
Image: Blood test for  plasma aldosterone concentration was used to screen For hyperaldosteronism in hypertensive men (Photo courtesy of  VisitHealth Ltd)

Urinary Sodium/Potassium Ratio Screens for Hyperaldosteronism in Hypertensive Men

Among individuals with hypertension, the prevalence of secondary hypertension has been reported to be around 10%. More than half of individuals with secondary hypertension have associated hyperaldosteronism.... Read more

Industry

view channel
Illustration

Global Clinical Chemistry Analyzers Market to Reach USD 15.97 Billion by 2028

The global clinical chemistry analyzers market is projected to grow at a CAGR of 4.25% from USD 11.45 billion in 2020 to USD 15.97 billion by 2028, driven by growth in technology, rising global population,... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.